Daksh Sinha

University of Washington

Papers

1

Total Citations

6

H-Index

1

About

Daksh Sinha is a rising leader in the intersection of microengineering and biomedicine, with a primary focus on low-cost robotic manipulation and microfluidic systems for cancer drug testing. His most-cited work, "Low-cost robotic manipulation of live microtissues for cancer drug testing" (2025, 6 citations), addresses a critical bottleneck in therapeutic development: the scarcity of human biopsies. By pioneering accessible microtechnologies that combine precise microscale tissue handling with fluidic control, Sinha enables the miniaturization of disease models and personalized drug screening, reducing reliance on costly, limited biological samples. His contributions offer a scalable, affordable platform for high-throughput testing, directly impacting the fields of personalized medicine and oncology. Though early in his career, Sinha’s work has already garnered attention for its potential to democratize drug testing, making it feasible for labs with constrained resources. His innovative approach—merging robotics with live tissue culture—positions him as a key figure in advancing translational microengineering, with implications for accelerating cancer therapy discovery and reducing animal testing.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Low-cost robotic manipulation of live microtissues for cancer drug testing
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Washington

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago